...
首页> 外文期刊>R & D Management >R&D and technology purchase through licence agreements: complementary strategies and complementary assets
【24h】

R&D and technology purchase through licence agreements: complementary strategies and complementary assets

机译:通过许可协议进行研发和技术购买:补充策略和补充资产

获取原文
获取原文并翻译 | 示例
           

摘要

This paper reports on a major UK-wide investigation into the role of inward technology licensing and in-house R&D as alternative and complementary strategies in new product and process development. The role of licensing in the technology strategy of the firm can be viewed as the 'buy' in the context of 'make or buy' technology decisions. Such technology purchases may be made for a number of reasons including insufficient in-house resources or gaps in R&D provision stemming from small scale, risk, low investment in research or diversification away from existing research competencies. However, technology markets might have substantial information imperfections and transaction costs. The tasks of finding a technology provider, transferring the technology inwards and absorbing it into commercially successful new products and processes, can inhibit the use of licensing agreements for technology acquisition. This research, using a sample of 128 manufacturing companies (including both licensees and non-licensees), examines some key propositions around the use of technology licensing. Data was collected on technology strategies, complementary assets, internal organisation and market structure. Analysis of the data suggests that strategies of 'buy and make' are complements rather than alternatives, and that extensive use of licensing requires substantial complementary assets to be in place. The nature of product-market positioning was found to be a significant driver of technology strategy, with firms that pursue product differentiation being the most likely to license. Whilst a priori it might be expected that internal organisation would influence technology strategy, this study was only able to provide weak support for this.
机译:本文报告了英国范围内的一项重大调查,调查了内向技术许可和内部研发在新产品和工艺开发中作为替代和补充策略的作用。在“制造或购买”技术决策的背景下,许可在公司技术战略中的作用可以被视为“购买”。购买此类技术的原因可能有很多,其中包括内部资源不足或由于规模小,风险,对研究的投资少或现有研究能力以外的多样化而导致的研发经费缺口。但是,技术市场可能存在重大的信息缺陷和交易成本。寻找技术提供商,向内转让技术并将其吸收到商业上成功的新产品和流程中的任务可能会禁止使用许可协议进行技术获取。这项研究以128家制造公司(包括被许可方和非被许可方)为样本,研究了有关技术许可使用的一些关键主张。收集了有关技术战略,互补资产,内部组织和市场结构的数据。对数据的分析表明,“购买与制造”策略是补充而非替代,并且许可的广泛使用需要大量的补充资产。人们发现,产品市场定位的本质是技术战略的重要驱动力,追求产品差异化的公司最有可能获得许可。先验的是,内部组织可能会影响技术战略,但这项研究只能为此提供薄弱的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号